Osteonecrosis of the hip: Novel approaches to evaluation and treatment

Clinical Orthopaedics and Related Research

Volumn 465, Issue , 2007, Pages 53-62

  Petrigliano, Frank A ^a   Lieberman, Jay R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BONE MORPHOGENETIC PROTEIN; CORTICOSTEROID; ILOPROST; STEROID; TANTALUM;

BONE GRAFT; BONE LESION; BONE MARROW DISEASE; BONE NECROSIS; CLINICAL TRIAL; CONFERENCE PAPER; DECOMPRESSION; DISEASE COURSE; DISEASE SEVERITY; GENETIC POLYMORPHISM; GROUPS BY AGE; HUMAN; IMPLANT; MEDICAL RESEARCH; MESENCHYMAL STEM CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL TECHNIQUE; TECHNOLOGY; TOTAL HIP PROSTHESIS; ARTHROPLASTY; BONE TRANSPLANTATION; DECOMPRESSION SURGERY; DRUG THERAPY; GENETIC PREDISPOSITION; GENETICS; HIP; HIP ARTHROPLASTY; HOSPITALIZATION; ORTHOPEDIC SURGERY; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT SELECTION; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

ARTHROPLASTY; ARTHROPLASTY, REPLACEMENT, HIP; BONE TRANSPLANTATION; DECOMPRESSION, SURGICAL; DRUG THERAPY; GENETIC PREDISPOSITION TO DISEASE; HIP JOINT; HUMANS; MAGNETIC RESONANCE IMAGING; ORTHOPEDIC PROCEDURES; OSTEONECROSIS; PATIENT SELECTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 37349010372     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/BLO.0b013e3181591c92     Document Type: Conference Paper

References (51)

1. Aaron RK. Treatment of osteonecrosis of the femoral head with electrical stimulation. Instr Course Lect. 1994;43:495-498.
2. Agarwala S, Jain D, Joshi VR, Sule A. Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study. Rheumatology (Oxford). 2005;44:352-359.
3. Baldwin C, Nolan VG, Wyszynski DF, Ma QL, Sebastiani P, Embury SH, Bisbee A, Farrell J, Farrer L, Steinberg MH. Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis. Blood. 2005;106:372-375.
4. Cui Q, Wang Y, Saleh KJ, Wang GJ, Balian G. Alcohol-induced adipogenesis in a cloned bone-marrow stem cell. J Bone Joint Surg Am. 2006;88(suppl 3):148-154.
5. Disch AC, Matziolis G, Perka C. The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous iloprost. J Bone Joint Surg Br. 2005;87:560-564.
6. Drescher W, Bunger MH, Weigert K, Bunger C, Hansen ES. Methylprednisolone enhances contraction of porcine femoral head epiphyseal arteries. Clin Orthop Relat Res. 2004;423:112-117.
7. Drescher W, Li H, Lundgaard A, Bunger C, Hansen ES. Endothelin-1-induced femoral head epiphyseal artery constriction is enhanced by long-term corticosteroid treatment. J Bone Joint Surg Am. 2006;88(suppl 3):173-179.
8. Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am. 2004;86:1153-1160.
9. Glueck CJ, Freiberg RA, Sieve L, Wang P. Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clin Orthop Relat Res. 2005;435:164-170.
10. Ha YC, Jung WH, Kim JR, Seong NH, Kim SY, Koo KH. Prediction of collapse in femoral head osteonecrosis: a modified kerboul method with use of magnetic resonance images. J Bone Joint Surg Am. 2006;88(suppl 3):35-40.
11. Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res. 2002;405:14-23.
12. Hernigou P, Poignard A, Nogier A, Manicom O. Fate of very small asymptomatic stage-I osteonecrotic lesions of the hip. J Bone Joint Surg Am. 2004;86:2589-2593.
13. Hungerford DS, Jones LC. Asymptomatic osteonecrosis: should it be treated? Clin Orthop Relat Res. 2004;429:124-130.
14. Ito H, Matsuno T, Minami A. Relationship between bone marrow edema and development of symptoms in patients with osteonecrosis of the femoral head. AJR Am J Roentgenol. 2006;186:1761-1770.
15. Jones LC, Hungerford DS. Osteonecrosis: etiology, diagnosis, and treatment. Curr Opin Rheumatol. 2004;16:443-449.
16. Koo KH, Lee JS, Lee YJ, Kim KJ, Yoo JJ, Kim HJ. Endothelial nitric oxide synthase gene polymorphisms in patients with nontraumatic femoral head osteonecrosis. J Orthop Res. 2006;24:1722-1728.
17. Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am. 2005;87:2155-2159.
18. Lavernia CJ, Sierra RJ, Grieco FR. Osteonecrosis of the femoral head. J Am Acad Orthop Surg. 1999;7:250-261.
19. Lee JS, Roh HL, Kim CH, Jung JS, Suh KT. Alterations in the differentiation ability of mesenchymal stem cells in patients with nontraumatic osteonecrosis of the femoral head: comparative analysis according to the risk factor. J Orthop Res. 2006;24:604-609.
20. Lieberman JR. Core decompression for osteonecrosis of the hip. Clin Orthop Relat Res. 2004;418:29-33.
21. Lieberman JR, Berry DJ, Mont MA, Aaron RK, Callaghan JJ, Rajadhyaksha AD, Urbaniak JR. Osteonecrosis of the hip: management in the 21st century. Instr Course Lect. 2003;52:337-355.
22. Lieberman JR, Conduah A, Urist MR. Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop Relat Res. 2004;429:139-145.
23. Liu YF, Chen WM, Lin YF, Yang RC, Lin MW, Li LH, Chang YH, Jou YS, Lin PY, Su JS, Huang SF, Hsiao KJ, Fann CS, Hwang HW, Chen YT, Tsai SF. Type II collagen gene variants and inherited osteonecrosis of the femoral head. N Engl J Med. 2005;352:2294-2301.
24. Marciniak D, Furey C, Shaffer JW. Osteonecrosis of the femoral head. A study of 101 hips treated with vascularized fibular grafting. J Bone Joint Surg Am. 2005;87:742-747.
25. Massari L, Fini M, Cadossi R, Setti S, Traina GC. Biophysical stimulation with pulsed electromagnetic fields in osteonecrosis of the femoral head. J Bone Joint Surg Am. 2006;88(suppl 3):56-60.
26. Matsusaki H, Noguchi M, Kawakami T, Tani T. Use of vascularized pedicle iliac bone graft combined with transtrochanteric rotational osteotomy in the treatment of avascular necrosis of the femoral head. Arch Orthop Trauma Surg. 2005;125:95-101.
27. Meizer R, Radda C, Stolz G, Kotsaris S, Petje G, Krasny C, Wlk M, Mayerhofer M, Landsiedl F, Aigner N. MRI-controlled analysis of 104 patients with painful bone marrow edema in different joint localizations treated with the prostacyclin analogue iloprost. Wien Klin Wochenschr. 2005;117:278-286.
28. Mont MA, Etienne G, Ragland PS. Outcome of nonvascularized bone grafting for osteonecrosis of the femoral head. Clin Orthop Relat Res. 2003;417:84-92.
29. Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am. 2006;88:1117-1132.
30. Mont MA, Marulanda GA, Seyler TM, Plate JF, Delanois RE. Core decompression and nonvascularized bone grafting for the treatment of early stage osteonecrosis of the femoral head. Instr Course Lect. 2007;56:213-220.
31. Mont MA, Ragland PS, Etienne G. Core decompression of the femoral head for osteonecrosis using percutaneous multiple small-diameter drilling. Clin Orthop Relat Res. 2004;429:131-138.
32. Mont MA, Seyler TM, Marker DR, Marulanda GA, Delanois RE. Use of metal-on-metal total hip resurfacing for the treatment of osteonecrosis of the femoral head. J Bone Joint Surg Am. 2006;8(suppl 3):90-97.
33. Mont MA, Seyler TM, Plate JF, Delanois RE, Parvizi J. Uncemented total hip arthroplasty in young adults with osteonecrosis of the femoral head: a comparative study. J Bone Joint Surg Am. 2006;88(suppl 3):104-109.
34. Nich C, Courpied JP, Kerboull M, Postel M, Hamadouche M. Charnley-Kerboull total hip arthroplasty for osteonecrosis of the femoral head a minimal 10-year follow-up study. J Arthroplasty. 2006;21:533-540.
35. Nich C. Sari Ali el H, Hannouche D, Nizard R, Witvoet J, Sedel L, Bizot P. Long-term results of alumina-on-alumina hip arthroplasty for osteonecrosis. Clin Orthop Relat Res. 2003;417:102-111.
36. Nishii T, Sugano N, Miki H, Hashimoto J, Yoshikawa H. Does alendronate prevent collapse in osteonecrosis of the femoral head? Clin Orthop Relat Res. 2006;443:273-279.
37. Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res. 2001;386:173-178.
38. Revell MP, McBryde CW, Bhatnagar S, Pynsent PB, Treacy RB. Metal-on-metal hip resurfacing in osteonecrosis of the femoral head. J Bone Joint Surg Am. 2006;88(suppl 3):98-103.
39. Rijnen WH, Gardeniers JW, Westrek BL, Buma P, Schreurs BW. Sugioka's osteotomy for femoral-head necrosis in young Caucasians. Int Orthop. 2005;29:140-144.
40. Scully SP, Aaron RK, Urbaniak JR. Survival analysis of hips treated with core decompression or vascularized fibular grafting because of avascular necrosis. J Bone Joint Surg Am. 1998;80:1270-1275.
41. Shannon BD, Trousdale RT. Femoral osteotomies for avascular necrosis of the femoral head. Clin Orthop Relat Res. 2004;418:34-40.
42. Shuler MS, Rooks MD, Roberson JR. Porous tantalum implant in early osteonecrosis of the hip preliminary report on operative, survival, and outcomes results. J Arthroplasty. 2007;22:26-31.
43. Squire M, Fehring TK, Odum S, Griffin WL, Bohannon Mason J. Failure of femoral surface replacement for femoral head avascular necrosis. J Arthroplasty. 2005;20:108-114.
44. Suh KT, Kim SW, Roh HL, Youn MS, Jung JS. Decreased osteogenic differentiation of mesenchymal stem cells in alcohol-induced osteonecrosis. Clin Orthop Relat Res. 2005;431:220-225.
45. Tsao AK, Roberson JR, Christie MJ, Dore DD, Heck DA, Robertson DD, Poggie RA. Biomechanical and clinical evaluations of a porous tantalum implant for the treatment of early-stage osteonecrosis. J Bone Joint Surg Am. 2005;87(suppl 2):22-27.
46. Vande Berg BC, Gilon R, Malghem J, Lecouvet F, Depresseux G, Houssiau FA. Correlation between baseline femoral neck marrow status and the development of femoral head osteonecrosis in corticosteroid-treated patients: a longitudinal study by MR imaging. Eur J Radiol. 2006;58:444-449.
47. Veillette CJ, Mehdian H, Schemitsch EH, McKee MD. Survivorship analysis and radiographic outcome following tantalum rod insertion for osteonecrosis of the femoral head. J Bone Joint Surg Am. 2006;88(suppl 3):48-55.
48. Wang CJ, Wang FS, Huang CC, Yang KD, Weng LH, Huang HY. Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone-grafting. J Bone Joint Surg Am. 2005;87:2380-2387.
49. Yen CY, Tu YK, Ma CH, Yu SW, Kao FC, Lee MS. Osteonecrosis of the femoral head: comparison of clinical results for vascularized iliac and fibula bone grafting. J Reconstr Microsurg. 2006;22:21-24.
50. Yin L, Li YB, Wang YS. Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis. Chin Med J (Engl). 2006;119:581-588.
51. Zhao D, Xu D, Wang W, Cui X. Iliac Graft vascularization for femoral head osteonecrosis. Clin Orthop Relat Res. 2006;442:171-179.